As of 2026-03-27, the Relative Valuation of Cymabay Therapeutics Inc (CBAY) is (14.46) USD. This relative valuation is based on P/E multiples. With the latest stock price at 32.48 USD, the upside of Cymabay Therapeutics Inc based on Relative Valuation is -144.5%.
The range of the Relative Valuation is (10.04) - (15.68) USD.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | 10.9x - 18.4x | 16.6x |
| Forward P/E multiples | 9.9x - 17.1x | 14.8x |
| Fair Price | (10.04) - (15.68) | (14.46) |
| Upside | -130.9% - -148.3% | -144.5% |
| Date | P/E |